AI Article Synopsis
- Pancreatic ductal adenocarcinoma (PDAC) is a severe cancer with low survival rates, primarily due to the lack of effective treatments.
- Pancreatic stellate cells (PSCs) in the tumor environment contribute to PDAC's progression by enhancing cancer cells' resistance to ferroptosis, a form of cell death.
- Research shows that PSCs secrete IL15, which activates pathways that increase GPX4 and ACSL3 levels, protecting cancer cells from oxidative damage, suggesting potential new treatment approaches for PDAC.
Article Abstract
Pancreatic ductal adenocarcinoma (PDAC) is a highly malignant disease with a poor prognosis, and the lack of effective treatment methods accounts for its high mortality. Pancreatic stellate cells (PSCs) in the tumor microenvironment play an important role in the development of PDAC. Previous studies have reported that patients with PDAC are more vulnerable to ferroptosis inducers. To investigate the relationship between PSCs and pancreatic cancer cells, a coculture system is used to further reveal the influence of PSCs on ferroptosis resistance in PDAC using many and experiments. Our results show that PSCs promote ferroptosis resistance in pancreatic cancer cells. We further demonstrate that IL15 secretion by PSCs activates the IL15RA-STAT3-GPX4/ACSL3 axis. The simultaneous upregulation of GPX4 and ACSL3 prevents lipid peroxidation and ultimately protects pancreatic cancer cells from ferroptosis both and . This study demonstrates that PSCs protect pancreatic cancer cells in a paracrine manner and may indicate a novel strategy for the treatment of PDAC.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.3724/abbs.2024153 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!